Standard AOD-9604 Dosing Protocol Subcutaneous Injection Dosing: Beginner: 250 mcg per dose, once daily Intermediate: 300-400 mcg per dose, once daily or divided into two doses Advanced: 500 mcg per dose, once daily or 250 mcg twice daily Oral Administration Dosing (if using oral formulation): Standard: 1-2 mg per dose, once daily on empty stomach Higher protocols: Up to 5-10 mg daily, as studied in clinical trials Frequency: Once daily (morning preferred) or twice daily (morning and early afternoon) Timing: Best administered on an empty stomach, typically upon waking or before exercise Cycle Length: 12-16 weeks for initial assessment, with potential for longer protocols based on response Off Cycle: 4-8 weeks between cycles, though not strictly required based on current research Note: Start at the lower end of the dosing range to assess individual tolerance
Resource two is the raw material used to build NAD+
This matters for measurement accuracy: a 100 mcg amount is 3 units from a 10 mg vial versus 6 units from a 5 mg vial, and at 3 units a single-unit misread is a 33% error
If your skin barrier is already damaged from over-exfoliation, eczema flares, or aggressive treatment protocols, adding any new active, including GHK-Cu, can cause irritation
Thats a gap the FDA is right to point at, and its a gap that legal compounding plus real trials would start to close
A 2025 systematic review (PMC, 36 studies, 1993-2024) found consistent improvement in tendon, ligament, muscle, and bone healing in animal models